Intercept Pharma (ICPT) Tops Q1 EPS by 64c

Intercept Pharma (NASDAQ: ICPT) reported Q1 EPS of ($3.61), $0.64 better than the analyst estimate of ($4.25). Revenue for the quarter came in at $21 million versus the consensus estimate of $15.8 million.

For earnings history and earnings-related data on Intercept Pharma (ICPT) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• 4D Molecular Therapeutics, Inc. (FDMT) Misses Q2 EPS by 3c
• Innovaro (INV) Misses Q2 EPS by 9c